Details
Category: Volume 07 Issue 10 October 2019
Hits: 1089

Title: Serum Levels of Osteoprotegerin in Patients with Acne Vulgaris

Authors: Ahmed A. W. Saleh, Rehab M. Salem, Asmaa A. El-Fallah, Haider S. Abdullah

 DOI: https://dx.doi.org/10.18535/jmscr/v7i10.98

Abstract

  

Background: Acne vulgaris (AV) is a common chronic inflammatory skin disease involving pilosebaceous follicles characterized by comedones, papules, pustules, nodules, and sometimes scars.

Aim of the Work: The aim of this study is to evaluate the serum levels of osteoprotegerin in patients with acne vulgaris and assess its relation to the severity of the disease.

Methods: This case-control study was conducted in the outpatient Clinic of Dermatology and Andrology, Department of Benha University. The study included 80 participants; 60 patients suffering from acne vulgaris, in addition to 20 apparently healthy, age and sex matched individuals as a control group. Determination of serum level of osteoprotegerin was done by ELISA technique.

Results: The mean serum level of OPG in patients group (124.390±5.741) was significantly higher than that in the control group (47.394±29.332) as p<0.001. At a Cutoff point >48.4, Serum OPG had 95% Sensitivity and 70% Specificity and 88.9% accuracy to differentiate between Patients and Controls.

Conclusion: Osteoprotegerin may play a role in acne pathogenesis.

Keywords: Acne vulgaris. osteoprotegerin, case-control.

References

  1. Bhate K and Williams HC (2013): Epidemiology of acne vulgaris. Br J Dermatol.; 168: 474-485.
  2. Dawson AL, Dellavalle RP (2013): Acne vulgaris. BMJ., 346: f2634.
  3. Abulnaja KO (2009): Changes in the hormone and lipid profile of obese adolescent Saudi females with acne vulgaris. Braz J Med BiolRes.; 42: 501-50.
  4. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Lüthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Boyle WJ (1997): "Osteoprotegerin: a novel secreted protein involved in the regulation of bone density". Cell. 89 (2): 309–19.
  5. Krakauer T (2008). Nuclear factor-kappaB: fine-tuning a central integrator of diverse biologic stimuli. International Reviews of Immunology. 27 (5): 286–92.
  6. Yun TJ, Chaudhary PM, Shu GL, Frazer JK, Ewings MK, Schwartz SM, Pascual V, Hood LE and Clark EA (1998): OPG/FDCR-1, a TNF receptor family member, is expressed in lymphoid cells and is up-regulated by ligating CD40. J Immunol.; 6113-6121.
  7. Brandstrom H, Bjorkmann T and Ljunggren O (2001): Regulation of osteoprotegerin secretion from primary cultures of human bone marrow stromal cells.BiochemBiophys Res Commun.;280:831-835.
  8. Loser K, Mehling A, Loeser S, Apelt J, Kuhn A, Grabbe S, et al (2006): Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells. Nat Med  12(12):1372–9.
  9. Sangwan D (2016): A study of body mass index between private and government school children.Int J PhysEduc Sports Health; 3 (1): 63-65.
  10. Doshi A, Zaheer A and Stiller MJ (1997):A comparison of current acne grading systems and proposal of a novel system. Int J Dermatol; 36(6): 416-8.
  11. Davis SA, Narahari S, Feldman SR, et al. (2012): Top dermatologic conditions in patients of color: an analysis of nationally representative data. Journal of drugs in dermatology: JDD 11: 466-473.
  12. Nybo M and Rasmussen LM. (2008): The capability of plasma osteoprotegerin as a predictor of cardiovascular disease: a systematic literature review. European Journal of Endocrinology 159: 603-608.
  13. Escobar-Morreale HF, Botella-Carretero JI, Martínez-García MÁ, et al. (2008): Serum osteoprotegerin concentrations are decreased in women with the polycystic ovary syndrome. European Journal of Endocrinology 159: 225-232.
  14. Rizvi F and Chaudry MA. (2009): Precipitating factors of acne vulgaris in females. Ann. Pak. Inst. Med. Sci 5: 104-107.
  15. El-Tonsy TMK, Mohammed MA, Hamed E-E, et al. (2018): Bacteriological study of Acne Vulgaris in Cairo Egypt. Egyptian Journal of Hospital Medicine 72.
  16. Tallab TM. (2004): Beliefs, perceptions and psychological impact of acne vulgaris among patients in the Assir region of Saudi Arabia. West African journal of medicine 23: 85-87.
  17. Zahra Ghodsi S, Orawa H and Zouboulis CC. (2009): Prevalence, Severity, and Severity Risk Factors of Acne in High School Pupils: A Community-Based Study. Journal of Investigative Dermatology 129: 2136-2141.
  18. Ismail KH and Mohammed-Ali KB. (2012): Quality of life in patients with acne in Erbil city. Health and quality of life outcomes 10: 60.
  19. Tan J and Bhate K. (2015b): A global perspective on the epidemiology of acne. British Journal of Dermatology 172: 3-12.
  20. Bagatin E, Timpano DL, Guadanhim LRdS, et al. (2014): Acne vulgaris: prevalence and clinical forms in adolescents from São Paulo, Brazil. Anais brasileiros de dermatologia 89: 428-435.
  21. Tan J and Bhate K. (2015a): A global perspective on the epidemiology of acne. British Journal of Dermatology 172: 3-12.
  22. Dikshit A, Qidwai A, Pandey M, et al. (2017): Risk factor assessment for acne vulgaris in human and implications for public health interventions in north central India: A surveybased study.
  23. QIDWAI A, PANDEY M, SHUKLA SK, et al. (2017): Risk factor assessment for acne vulgaris in human and implications for public health interventions in North Central India: a survey-based study. RISK 10.
  24. Bowe WP, Joshi SS and Shalita AR. (2010): Diet and acne. Journal of the American Academy of Dermatology 63: 124-141.
  25. Alanazi MS, Hammad SM and Mohamed AE. (2018): Prevalence and psychological impact of Acne vulgaris among female secondary school students in Arar city, SaudiArabia, in 2018. Electron Physician 10: 7224-7229.
  26. El‐Hamd MA, Nada EEDAa, Moustafa MAK, et al. (2017): Prevalence of acne vulgaris and its impact of the quality of life among secondary school‐aged adolescents in Sohag Province, Upper Egypt. Journal of cosmetic dermatology 16: 370-373.
  27. Holecki M, Zahorska‐Markiewicz B, Janowska J, et al. (2007): The influence of weight loss on serum osteoprotegerin concentration in obese perimenopausal women. Obesity 15: 1925-1929.
  28. Yin Y, Hou X-h, Pan X-p, et al. (2009): Serum vaspin level in relation to postprandial plasma glucose concentration in subjects with diabetes. Chinese medical journal 122: 2530-2533.
  29. Avignon A, Sultan A, Piot C, et al. (2007): Osteoprotegerin: a novel independent marker for silent myocardial ischemia in asymptomatic diabetic patients. Diabetes Care 30: 2934-2939.
  30. Genc M, Can M, Guven B, et al. (2017): Evaluation of Serum Fetuin-A and Osteoprotegerin Levels in Patients with Psoriasis. Indian Journal of Clinical Biochemistry 32: 90-94.
  31. Lappin DF, Sherrabeh S, Jenkins WMM, et al. (2007): Effect of smoking on serum RANKL and OPG in sex, age and clinically matched supportive-therapy periodontitis patients. Journal of Clinical Periodontology 34: 271-277.

Corresponding Author

Haider Sameer Abdullah